Showing 1 - 10 of 27
Persistent link: https://www.econbiz.de/10013375056
The main objective of this study is to investigate the impact of corporate R&D activities on firms' performance, measured by labour productivity. To this end, the stochastic frontier technique is applied, basing the analysis on a unique unbalanced longitudinal dataset consisting of 532 top...
Persistent link: https://www.econbiz.de/10010269441
The purpose of this study is to investigate the relationship between a firm's R&D expenditures considered as an investment in knowledge, and its productivity, looking at sectoral peculiarities which may emerge; to this end, we use a large unique longitudinal database consisting of 1,809 US and...
Persistent link: https://www.econbiz.de/10010280726
The main objective of this study is to investigate the impact of corporate R&D activities on firms' performance, measured by labour productivity. To this end, the stochastic frontier technique is applied, basing the analysis on a unique unbalanced longitudinal dataset consisting of 532 top...
Persistent link: https://www.econbiz.de/10003931968
Persistent link: https://www.econbiz.de/10009381330
Persistent link: https://www.econbiz.de/10010516626
Persistent link: https://www.econbiz.de/10009614545
The importance of SMEs in Europe's innovation process can be seen in both the academic and the political arena. Adopted in June 2008, the 'Small Business Act' for Europe reflects the Commission's political will to recognise the central role of SMEs in the EU economy and was the first to put in...
Persistent link: https://www.econbiz.de/10012056191
The main objective of this study is to investigate the impact of corporate R&D activities on firm performance, measured by labour productivity. To this end, the stochastic frontier technique is used on a unique unbalanced longitudinal dataset on top European R&D investors over the period...
Persistent link: https://www.econbiz.de/10011981958
Health represents one of the thematic priorities for smart specialisation. Until now the difficulty in properly measuring research and innovation (R&I) in Health sector has represented a barrier to address specific policies in favour of less performing regions. This is due to two factors: a lack...
Persistent link: https://www.econbiz.de/10014119102